Geneva, Switzerland, September 5, 2018 – Abologix has been selected to participate in the incubation program sponsored by Fondation Eclosion. As part of this program Abologix will receive business, scientific and financial support from Fondation Eclosion. The company will receive 150,000 CHF in the form of a convertible loan.
top of page
Geneva, Switzerland, December 23, 2024 – Abologix has been awarded 100,000 CHF by the KICK FUND to progress its advanced preclinical...
Geneva, Switzerland, November 23, 2023 – Abologix successfully completes the Innosuisse-funded program for the initial characterization...
Geneva, Switzerland, December 20, 2022 – Abologix nominates monoclonal antibody H225 (blocker of JAM-C, Junction Adhesion Molecule C) as...
bottom of page
Comentarios